Serveur d'exploration Tocilizumab - Curation (Istex)

Index « AbsEn.i » - entrée « significant »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
significance < significant < significantly  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 88.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000010 (2011) Katsuaki Kanbe [Japon] ; Atsushi Nakamura [Japon] ; Yasuo Inoue [Japon] ; Kaori Hobo [Japon]Osteoprotegerin expression in bone marrow by treatment with tocilizumab in rheumatoid arthritis
000013 (2013) Micha Levi [États-Unis] ; Susan Grange [États-Unis] ; Nicolas Frey [Suisse]Exposure‐Exposure Relationship of Tocilizumab, an Anti–IL‐6 Receptor Monoclonal Antibody, in a Large Population of Patients With Rheumatoid Arthritis
000017 (2011) Katsuaki Kanbe [Japon] ; Qian Chen [États-Unis] ; Atsushi Nakamura [Japon] ; Kaori Hobo [Japon]Inhibition of MAP kinase in synovium by treatment with tocilizumab in rheumatoid arthritis
000039 (2011) Toshio Tanaka [Japon] ; Keisuke Hagihara [Japon] ; Yoshihito Shima [Japon] ; Masashi Narazaki [Japon] ; Atsushi Ogata [Japon] ; Atsushi Kumanogoh [Japon]Tocilizumab, a humanized anti‐interleukin‐6 receptor antibody, for the treatment of autoimmune disorders
000044 (2010) Yoh Arita [Japon] ; Yasushi Sakata [Japon] ; Takao Sudo [Japon] ; Tetsuo Maeda [Japon] ; Ken Matsuoka [Japon] ; Keito Tamai [Japon] ; Kaori Higuchi [Japon] ; Wataru Shioyama [Japon] ; Yoshikazu Nakaoka [Japon] ; Yuzuru Kanakura [Japon] ; Keiko Yamauchi-Takihara [Japon]The efficacy of tocilizumab in a patient with pulmonary arterial hypertension associated with Castleman’s disease
000048 (2012) Hiroki Wakabayashi [Japon] ; Masahiro Hasegawa [Japon] ; Yosuke Nishioka [Japon] ; Yukari Minami [Japon] ; Kusuki Nishioka [Japon] ; Akihiro Sudo [Japon]Clinical outcome in patients with rheumatoid arthritis switched to tocilizumab after etanercept or infliximab failure
000057 (2007) Peter Taylor [Royaume-Uni]IL‐6 inhibition in the treatment of rheumatoid arthritis
000058 (2014) Lucie M. Turcotte [États-Unis] ; Colleen K. Correll ; Robyn C. Reed ; Christopher L. MoertelSustained remission of severe multicentric castleman disease following multiagent chemotherapy and tocilizumab maintenance
000071 (2010) A. Gause [Allemagne] ; A. Rubbert-Roth [Allemagne] ; H. Michels [Allemagne] ; M. Gaubitz [Allemagne] ; W.-J. Mayet [Allemagne]Empfehlungen der Deutschen Gesellschaft für Rheumatologie zum Einsatz von Tocilizumab bei der rheumatoiden Arthritis (Februar 2010)
000088 (2011) Emily Beth Devine [États-Unis] ; Rafael Alfonso-Cristancho [États-Unis] ; Sean D. Sullivan [États-Unis]Effectiveness of Biologic Therapies for Rheumatoid Arthritis: An Indirect Comparisons Approach
000099 (2010) Chi Chiu Mok [Hong Kong] ; Lai Shan Tam [Hong Kong] ; Tak Hin Chan [Hong Kong] ; Gavin K. W. Lee [Hong Kong] ; Edmund K. M. Li [Hong Kong]Management of rheumatoid arthritis: consensus recommendations from the Hong Kong Society of Rheumatology
000102 (2011) Masahiko Suzuki [Japon] ; Keiichiro Nishida [Japon] ; Satoshi Soen [Japon] ; Hiromi Oda [Japon] ; Hiroshi Inoue [Japon] ; Atsushi Kaneko [Japon] ; Kenji Takagishi [Japon] ; Takaaki Tanaka [Japon] ; Tsukasa Matsubara [Japon] ; Naoto Mitsugi [Japon] ; Yuichi Mochida [Japon] ; Shigeki Momohara [Japon] ; Toshihito Mori [Japon] ; Toru Suguro [Japon]Risk of postoperative complications in rheumatoid arthritis relevant to treatment with biologic agents: a report from the Committee on Arthritis of the Japanese Orthopaedic Association
000113 (2005) Josef S. Smolen [Autriche] ; Kurt Redlich [Autriche] ; Jochen Zwerina [Autriche] ; Daniel Aletaha [Autriche] ; Günter Steiner [Autriche] ; Georg Schett [Autriche]Pro-inflammatory cytokines in rheumatoid arthritis
000120 (2011) Rene Thonhofer [Autriche] ; Manuela Hiller [Autriche] ; Horst Just [Autriche] ; Markus Trummer [Autriche] ; Cornelia Siegel [Autriche] ; Christian Dejaco [Autriche]Treatment of refractory adult-onset still’s disease with tocilizumab: report of two cases and review of the literature
000133 (2009) Shin-Ya Kawashiri [Japon] ; Atsushi Kawakami [Japon] ; Satoshi Yamasaki [Japon] ; Takahiro Imazato [Japon] ; Naoki Iwamoto [Japon] ; Keita Fujikawa [Japon] ; Toshiyuki Aramaki [Japon] ; Mami Tamai [Japon] ; Hideki Nakamura [Japon] ; Hiroaki Ida [Japon] ; Tomoki Origuchi [Japon] ; Yukitaka Ueki [Japon] ; Katsumi Eguchi [Japon]Effects of the anti-interleukin-6 receptor antibody, tocilizumab, on serum lipid levels in patients with rheumatoid arthritis
000143 (2012) Maxime Samson [France] ; Sylvain Audia [France] ; Nona Janikashvili [France] ; Marion Ciudad [France] ; Malika Trad [France] ; Jennifer Fraszczak [France] ; Paul Ornetti [France] ; Jean-Francis Maillefert [France] ; Pierre Miossec [France] ; Bernard Bonnotte [France]Brief Report: Inhibition of interleukin‐6 function corrects Th17/Treg cell imbalance in patients with rheumatoid arthritis
000150 (2012) O. Psenak [Autriche] ; A. Studnicka-Benke [Autriche] ; R. Greil [Autriche]Sicherheit der Immunsuppressiva
000160 (2011) Susumu Nishiyama [Japon] ; Tetsushi Aita [Japon] ; Yasuhiko Yoshinaga [Japon] ; Hiroki Kishimoto [Japon] ; Michio Toda [Japon] ; Yoshiki Yoshihara [Japon] ; Shinya Miyoshi [Japon] ; Akira Manki [Japon] ; Shoji Miyawaki [Japon]Proposing a method of regional assessment and a novel outcome measure in rheumatoid arthritis
000172 (2011) Maneesh Gogia [États-Unis] ; Daniel E. Furst [États-Unis]Rheumatoid arthritis and pregnancy: Disease activity, pregnancy outcomes, and treatment options during pregnancy and lactation
000190 (2008) N. Leuchten [Allemagne] ; M. Aringer [Allemagne]Rheumatoide Arthritis/chronische Polyarthritis heute
000240 (2013) Naoshi Nishina [Japon] ; Yuko Kaneko [Japon] ; Hideto Kameda [Japon] ; Masataka Kuwana [Japon] ; Tsutomu Takeuchi [Japon]Reduction of plasma IL-6 but not TNF-α by methotrexate in patients with early rheumatoid arthritis: a potential biomarker for radiographic progression

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "significant" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "significant" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    significant
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021